Bio-Rad Laboratories
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $667,500 | $649,729 | $638,476 | $610,820 |
Gross Profit | 342,000 | 355,903 | 355,719 | 326,466 |
EBITDA | 58,400 | 922,894 | -2,727,417 | 551,155 |
EBIT | -896,700 | 873,794 | -2,774,017 | 503,355 |
Net Income | -715,800 | 653,172 | -2,165,486 | 383,916 |
Net Change In Cash | 667,500 | 649,729 | 638,476 | 610,820 |
Free Cash Flow | 81,248 | 99,971 | 55,365 | 29,616 |
Cash | 488,100 | 411,753 | 407,297 | 433,331 |
Basic Shares | 27,997 | 27,985 | 28,395 | 28,537 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,566,500 | $2,671,262 | $2,802,249 | $2,922,545 |
Gross Profit | 1,378,900 | 1,426,946 | 1,567,330 | 1,640,661 |
EBITDA | -2,142,000 | -608,264 | -4,488,959 | 5,627,505 |
EBIT | -2,293,600 | -754,164 | -4,666,159 | 5,450,605 |
Net Income | -1,844,200 | -637,324 | -3,627,535 | 4,254,257 |
Net Change In Cash | 2,566,500 | 2,671,262 | 2,802,249 | 2,922,545 |
Cost of Revenue | -39,570 | -195,982 | ||
Free Cash Flow | 266,200 | 218,263 | 80,290 | 535,718 |
Cash | 488,100 | 403,815 | 434,215 | 470,783 |
Basic Shares | 28,214 | 29,209 | 29,785 | 30,208 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $2.90 |
2024-09-30 | $2.01 |
2024-06-30 | $3.11 |
2024-03-31 | $2.29 |
